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Abstract 
 
Mesencymal stem cells (MSCs) are isolated from various mesenchymal tissues and differentiate 
into osteoblast, myocyte, and adipocyte. MSCs are easily obtained without ethical issue, and 
modulation of MSCs differentiation applies to various therapies. Moreover, the significance of 
modulating factor in MSCs differentiation is on the rise, we identified Propyl gallate, which can 
regulate differentiation of MSCs. PG is used as an additives in various foods that has antioxidant and 
anti-inflammatory effects. Although the function of PG is well identified in different cell types, it is 
unknown that PG has an effect on stem cell differentiation. We demonstrate that PG suppresses 
adipocyte differentiation in human adipose tissue-derived mesenchymal stem cells (hAMSCs) by 
reduced lipid droplets accumulation. Further, PG reduced expression of adipocyte-specific markers, 
including PPAR-γ, C/EBP-α, adipocyte fatty acid-binding protein and lipoprotein lipase. PG inhibited 
adipogenesis of hAMSCs through ERK pathway and the inhibition was recovered in response to 
blockage of ERK activation. Collectively these results demonstrate unusual function of PG on 
adipocyte differentiation in hAMSCs and PG inhibits adipocyte differentiation through ERK signaling 
pathway and decrease of PPAR-γ activity.  
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1. Introduction 
 
Mssenchymal stem cells (MSCs) are multi-potent adult stem cells that derived from various tissues, 
containing liver, spleen, muscle, bone marrow and adipose tissue23. MSCs have self-renewal ability 
while sustaining their capacity to differentiate into multi-lineage tissues. MSCs differentiate into 
chondrocytes, osteocytes and adipocytes3a, 24. Adipose tissue is one of the richest sources of MSCs. 
Adipose tissue has more than 500 times more MSCs in each 1 gram of tissue when compared to bone 
marrow. Human adipose tissue-derived mesenchymal stem cells (AMSCs) are currently actively 
being researched in clinical trials for treatment in a variety of diseases. Based on these properties, 
regulating differentiation and suppressing adipocyte differentiation of MSCs might be very interesting 
treatment of obesity. Example, Berberine, is a quaternary ammonium salt from many herbs, inhibits 
adipocyte differentiation cause normal mouse weight in obesity mice25. Therefore, research of the 
factors that modulate MSC differentiation is mightily important for suppressing obesity. 
 
 
Figure 1 - 1.   Mesenchymal stem cells 
 
The adipocyte differentiation progress, which produces mature adipocytes from pre-adipocytes, 
considerably determines the number of adipocytes22. The progress of adipocyte differentiation 
consists of determination and terminal differentiation phase. The determination phase causes the 
transformation of the stem cell to a pre-adipocyte without morphological change. Subsequently, 
terminal differentiation phase obtains the property of mature adipocyte from pre-adipocyte, and 
causes adipogenic proteins secretion, lipid transport and synthesis. Furthermore, terminal 
differentiation phase goes along a succession of transcriptional progress. Stimulated both of C/EBP-β  
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Figure 1 - 2.  The process of adipocyte differentiation 
 
and C/EBP-δ by adipocyte induced- hormone induces activation of PPAR-γ and C/EBP-α, and PPAR-
γ play a role as transcription factors modulating genes expression in adipocyte differentiation6,7,8. 
Those PPAR-γ modulated adipogenic genes are lipoprotein lipase (LPL), perilipin, fatty acid transport 
protein-1 (FATP-1), adipocyte fatty acid–binding protein (aP2) or adiponectin, which work with lipid 
accumulation and the regulation of metabolism in adipocyte differentiation9. After determination and 
terminal adipocytes differentiation phase, MSCs become mature adipocyte and the result of mature 
adipocyte make up obesity in a broad sense. Therefore, comprehending adipocyte differentiation is 
not only important in biology, it is also necessary to treat metabolic diseases such as type II diabetes 
and obesity.  
 
 
 
 
Figure 1 - 3. Transcriptional regulation in Adipocyte differentiation 
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One of the well-known signaling pathways in regulation of adipocyte differentiation is mitogen-
activated protein kinases (MAPKs). MAPKs are serine/threonine-specific protein kinases, which are 
involved in diverse signaling pathways such as cell proliferation, cell death and differentiation. There 
are three typical MAPKs including the extracellular signal regulated kinase (ERK1/2), the c-Jun N-
terminal kinase/stress-activated protein kinase (JNK/SAPK) and the p3826. These MAPKs pathways 
are connected with diverse upstream activators and particular substrates27. Numerous reports 
demonstrate that MAPKs associate with regulation of adipocyte differentiation. ERK and JNK inhibit 
the adipocyte differentiation in hAMSC, whereas p38 positively regulates adipocyte differentiation12. 
Furthermore, In case of ERK, inhibition of ERK promotes adipocyte differentiation without adipocyte 
induced-hormone and it prevents osteogenic differentiation of hAMSCs11.  
 
 
Figure 1 - 4.  The MAPKs signaling pathway 
 
To identify the novel factor that modulates adipocyte differentiation, we performed stem cell-based 
screen of the food additives library. As the result of screening, we found propyl gallate (3,4,5-
trihydroxybenzoic acid propyl ester, PG) has a novel function that inhibits adipocyte differentiation in 
AMSC. PG, which is an ester form of gallic acid with n-propanol, is synthetic antioxidants such as 
butylatedhydroxyanisole (BHA), butylatedhydroxytoluene (BHT), tert- ethylenediaminetetraacetic 
acid (EDTA), or butylhydroquinone (TBHQ)15 in wide range of products in foods, cosmetics, hair 
products, adhesives, lubricants and food packing materials and pharmaceutical industry13. In food 
industry, PG is added to vegetable oil, mayonnaise, meat, soup, milk powder, spices, candies, snacks, 
vitamins and chewing gum. It is practically used as a food additive (especially oils and fats) permitted 
in the Korea and in many countries16 The cellular toxicity of PG has been studied in vivo17 and in vitro 
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to evaluate diverse toxicological characteristics, such as mutagenicity18 and cytogenetic effects19. 
Nevertheless, although the properties of PG have been well investigated, the functions of PG remain 
unknown on stem cell differentiation. 
 
 
 
 
 
 
Figure 1 - 5. Structure of Propyl gallate 
 
This study demonstrates influence of PG in adipocyte differentiation of hAMSCs. PG inhibits 
adipocyte differentiation program and lipid droplet formation in hAMSCs via activation of ERK and 
inhibition of PPAR-γ activity. These results suggest a new function of PG in stem cell differentiation 
and molecular mechanism of anti-adipogenic activity of PG.  
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2. Materials and Methods 
 
2.1. Materials 
PG, Oil red O, 3-isobutyl-1-methylxanthine, dexamethasone, indomethacin, insulin, rosiglitazone 
and methyl thiazolyltetrazolium (MTT) was from Sigma-Aldrich. Santa Cruz Biotechnology (Santa 
Cruz) provides PPAR-γ, C/EBP-α, aP2, and ERK2 antibodies. Additionally p-JNK, p-ERK1/2 and p-
p38 antibodies were purchased from Cell Signaling Technology (Beverly). Antibody for Actin was 
from MP Biomedicals. Anti- rabbit and anti-mouse horseradish peroxidase-conjugated secondary 
antibodies were from KPL (Gaithersburg). PD98059 was obtained from Calbiochem. 
 
2.2. Cell culture  
After getting informed consent, individual undergoing elective surgery provides subcutaneous 
adipose tissues. The patient was woman aged 28 years. hAMSCs were isolated from adipose tissue in 
accordance with previous described method23a. hAMSCs were cultured in growth medium (GM) 
consisting of α-MEM added with 100 U/mL penicillin, 100 mg/mL streptomycin (Gibco- Invitrogen) 
and 10% FBS. The hAMSC of Passage numbers 3-10 were used in experiments.  
 
2.3. Induction of adipocyte differentiation 
hAMSCs were cultured in GM before inducing differentiation. Culturing the hAMSCs with 
adipogenic induction medium (AIM, 10% FBS, 1 µM dexamethasone, 100 µM indomethacin, 500 
µM 3-isobutyl-1-methylxanthine, and 1 µM insulin in α-MEM) for 14 days induce adipocyte 
differentiation. Every 3 days, AIM was changed and the cells were incubated in AIM but consisting 1 
µM insulin and 10% FBS in α-MEM after 9 days. Oil red O, as an indicator of intracellular lipid 
accumulation, stains differentiated adipocytes  
 
2.4. Oil red O staining 
For 14 days, cells were cultured with AIM to induce adipocyte differentiation. Differentiated 
adipocytes have lipid accumulations from hAMSCs and accumulated lipid were stained by Oil red O 
solution. Phosphate buffered saline (PBS) wash differentiated cells and fixation solution(4% 
paraformaldehyde) were incubated with the cells at 4℃for 2 h. After washing the cells twice with 
PBS, cells were stained by 0.5% Oil red O solution (Isopropanol: Distilled water = 6: 4. Before dilute 
in the water, 0.5% Oil red O powder dissolve in 6 parts isopropanol) for 1 h at 4℃. And washing the 
cells twice with PBS again, pictures of the cells were taken with Olympus IX 71 microscope at the 
UNIST-Olympus Biomed Imaging Center (UOBC).  
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To measure quantitative analysis of Oil red O staining, the stained Oil red O of cells dissolve in 
isopropanol for half-hour. Absorbance of the Oil red O-consisted isopropanol was analyzed at 540 nm 
with SpectraMax® M5 Multi-Mode Microplate Reader (Molecular Devices). 
 
2.5. Cell Viability Assay. 
hAMSCs were prepared at 104cells/well in a 96-well plate . MTT stock solution contains Thiazolyl 
Blue Tetrazolium Bromid (5 mg/mL) in phosphate-buffered saline (PBS) and was filtered. A final 
concentration of MTT stock solution in culture medium should be 0.5 mg/mL and then incubation of 
the plates are required at 37°C for 3h 30min. MTT solution produce formazan crystals and it melt in 
100 μl DMSO. The absorbance values of the samples was determined at 490 nm using SpectraMax® 
M5 Multi-Mode Microplate Reader (Molecular Devices). 
 
2.6. Real-time quantitative polymerase chain reaction (RT-PCR) 
Total RNA was prepared from hAMSCs using TRIzol reagent (Invitrogen). Moloney murine 
leukemia virus reverse transcriptase (Promega Corp.) efficiently reverse transcribe 1.5 μg total 
cellular RNA into cDNA with oligo(dT) primers. For real-time PCR , cDNA was amplified with the 
next primers by the Light Cycler 2.0 PCR system (Roche Diagnostics): C/EBP-α [5′-
AACCTTGTGCCTTGGAAATG-3′, 5′-CCTGCTCCCCTCCTTCTCT-3′], PPAR-γ [’-
ATGGAGTCCACGAGATCATT-3’, 5’-CGCAGGCTCTTTAGAAACTC-3’ ], LPL [5′-
CTGGACGGTAACAGGAATGTATGAG-3′, 5′-CATCAGGAGAAAGACGACTCGG-3′ ] 
adiponectin [5′-ACCACTATGATGGCTCCACT-3′, 5′-GGTGAAGAGCATAGCCTTGT-3′ ], aP2 
[5′-AACCTTAGATGGGGGTGTCCTG-3′, 5′-TCGTGGAAGTGACGCCTTTC-3′], ribosomal 
protein large P0 (RPLP0) [5′-GGAATGTGGGCTTTGTGTTC-3′, 5′-
TGCCCCTGGAGATTTTAGTG-3′]. For amplifying cDNA, Real-time PCR conditions are made up 
a hot start 10-min at 95°C, 45 cycles of 15s at 95°C, 10s at 60°C, and followed by 30s at 72°C. 
Expression level of RPLP0 is used for normalization of quantitative real-time PCR. 
 
2.7. Western blot analysis 
The cells lysate were prepared with lysis buffer (1% Triton X-100, 10% glycerol, 150 mM NaCl, 
50 mM HEPES, 1 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM phenylmethysulfonyl 
fluoride, 10 mg/mL leupeptin, 10 mg/mL aprotinin and pH 7.3, 1 mM EGTA). Centrifugation 
(14,000rpm for 15 min at 4oC) of the cell lysate isolates total proteins and quantitative analysis of 
protein was measured by Bradford protein concentration assay (Bio-Rad). 8 - 12% SDS-
polyacrylamide gel present the samples with electrophoresis and the samples were electrophoretically 
transferred to nitrocellulose membranes. After 5% skin milk block membranes, primary antibodies 
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were incubated with membranes and reach to the proteins of membranes (overnight at 4°C). After the 
suitable horseradish peroxidase-conjugated antibodies incubate with membranes, antibodies were 
developed using Enhanced chemiluminescence (ECL system; GE Healthcare). 
 
2.8. Transfection and luciferase activity assay 
For transfection, 3 x PPRE-tk-LUC plasmid, which has 3 copies of the PPAR-γ response element, 
pSV-PPAR-γ2 and pRL-SV40 construct, which expresses renilla luciferase (Promega Corporation), 
were prepared. The transfection was carried out following the procedure described by the 
Lipofectamine® 2000 instructions. To investigate the effect of PG on PPAR-γ activation, the Human 
embryonic kidney 293 (HEK293, 5×104cells/well) cells were prepared into 24-well plates. When the 
cells in 24-well plates reaches to approximately 70-80% of density, DNA mixture were transfected in 
the cells using Lipofectamine® 2000 for 24h. DNA mixtures consist of the pRL-SV-40 (25 ng), pSV-
PPAR-γ2 (0.1 μg) and 3 x PPRE-tk-LUC plasmid (0.1 μg). After transfection, the cells were cultured 
with following treatments of rosiglitazone, PPAR-γ ligand, and PG for an additional 36 h. Acc0ording 
to the manufacturer’ instruction, the luciferase activity assay was measured with the Dual-Luciferase 
Reporter Assay System (Promega Corporation). Renilla luciferase activity was in used for 
normalization of relative luciferase activity. 
 
2.9. Statistical analysis 
Data are expressed as mean ± standard deviation for independent experiments. Statistical 
significance test was estimated by Student's t-test and differences were significantly considered at 
p<0.05. All statistical tests were performed using SPSS for Windows version 18.0 (SPSS, Chicago, IL, 
USA). 
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3. Results 
 
3.1. PG reduces lipid droplet formation 
hAMSCs were cultured with AIM in the presence of PG for investing the function of PG on 
adipocyte differentiation. At 10 days after the initiating differentiation, the lipid accumulation and a 
characteristic of the adipocyte formation process was monitored using Oil red O staining. PG-treated 
hAMSCs show major changes as compared with the vehicle control in adipocyte differentiation 
condition. Treatment with PG significantly reduced accumulation of lipid droplets in a dose-
dependent manner (Fig. 1B). Quantification of the Oil Red O staining also indicates that PG 
suppresses adipocyte differentiation in hAMSCs (Fig. 1C). Additionally, we test the effect of PG on 
cellular viability with MTT assay in AIM. It presents that PG has no influence in cellular viability up 
to 30 μM (Fig. 1D). Therefore, these experiments demonstrate that PG suppresses adipocyte 
differentiation without the effect on cellular viability. 
 
3.2. The expression of adipogenic genes are decreased by PG  
During adipocyte differentiation, the expression of diverse transcriptional factors and adipogenic 
genes has significant role for regulating adipocyte differentiation28. To substantiate these phenotype 
results, we check the expression level of PPAR-γ and C/EBP-α, both major factors are required in 
adipocyte differentiation, with quantitative real-time PCR. We also examine expression of 
adipogenicgenes as LPL, aP2 and adiponectin, which are expressed during late or terminal stage of 
differentiation. These mRNA level was significantly decreased at the condition of AIM with 10uM 
PG. Inhibition of both PPAR-γ and C/EBP-α expressions was started by PG at 6days (Fig. 2A). 
Moreover, co-treatment of AIM and PG reduce the protein expression of adipogenic markers; PPAR-γ, 
C/EBP-α and aP2 (Fig. 2B). These results demonstrate that expression of adipogenic genes are 
suppressed by PG. 
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Figure 2 - 1. PG suppresses lipid accumulation in hAMSCs 
(A) Structure of PG (B) Every 3 days, hAMSCs was cultured with indicated doses of PG in GM or 
AIM. On day 14, the differentiated cells were stained by Oil red O staining and the staining presents 
the lipid accumulation. (Magnifications×100 and ×400) (C) Oil red O staining was quantified by 
dissolving in isopropanol for a half hour and absorbance of isopropanol was measured at 540 nm. On 
the 14 days, GM-cultured cells were presented as 1 in measurement of the mean value. Values present 
the mean ± SD. (D) hAMSCs were incubated with or without 1 - 100 µM PG in AIM. MTT assay 
shows the cellular viability. The mean value of 4day-cultured cells were presented as 100. Values 
present the mean ± SD (*p<0.05). All of experiments are represented in triplicates. Error bars present 
the range of experiment thrice. 
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Figure 2- 2. mRNA and protein level of adipocyte-specific genes were decreased in PG condition 
(A) hAMSCs were incubated with or without 10 µM PG in AIM. Gene expression of PPAR-γ, 
C/EBP-α, LPL, aP2, and adiponectin was examined by Real time-PCR. The mean values of 0day 
were presented as 1. (B) During adipocyte differentiation the protein level of PPAR-γ, C/EBP-α and 
aP2 was detected by western blot at the indicated time. All of experiments are represented in 
triplicates. β - actin are used as a normalization. 
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3.3. PG decreases PPAR-γ activity 
For adipocyte differentiation, PPAR-γ is a significant transcriptional factor29 and it has been known 
that some natural compounds modulate adipocyte differentiation by regulating PPAR-γ activity30. 
According to this reports, we test that whether PG reduces adipocyte differentiation by regulating 
PPAR-γ activity. In that hAMSCs has very low efficiency in the gene transfection, HEK293 cells 
were used to check the function of PG on PPAR-γ activity.  To measure the PPAR-γ activity, three 
different plasmids, which are renilla luciferase expression vector, PPAR-γ2 expression vector and 
PPREx3-tk-luciferase reporter vector, were transfected in HEK293 cells. Rosiglitazone (100 nM, a 
PPAR-γ ligand) is used for inducing PPAR-γ activation and works as a positive control. When PPAR-
γ was activated, co-treatment with PG effectively inhibits PPAR-γ activity of in a dose-dependent 
manner (Fig. 3). These results support that PG suppresses PPAR-γ activation.  
 
 
 
  
Figure 2 - 3. PG inhibits PPAR-γ activity 
PPAR-γ2 expression vector, PPREx3-tk-luciferase reporter plasmid and pRL-SV40 vector were 
transfected (12 hours) in HEK293 cells. After transfection, the cells were incubated with 100nM 
rosiglitazone and 10uM PG for 36 h. The relative luciferase activity indicates normalized mean value 
of Firefly luciferase activity by activity of renilla luciferase. Renilla was used as transfection control. 
The mean values of vehicle-cultured cells were presented as 1. Values represent the mean ± 
SD.*p<0.05 (compared to control). 
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3.4. PG negatively regulate adipocyte differentiation via ERK activation 
It has been known that MAPKs are involved in adipocyte differentiation from hMSCs. The 
activation of ERK and JNK signaling suppress the adipocyte differentiation whereas P38 promoted 
it12. The previous research demonstrated that a number of compounds regulate adipocyte 
differentiation through modulating MAPK activity23a, 31. Based on these studies, we demonstrate that 
PG reduces adipocyte differentiation by controlling MAPKs activity. In serum free condition, PG 
induced phosphorylation of ERK1/2 and p38, but not JNK phosphorylation (Fig. 4A). In addition, 
treatment of PG potentiated the ERK1/2 and p38 phosphorylation under AIM condition, compared 
with the vehicle control (Fig. 4B, C). 
To establish whether PG inhibits adipocyte differentiation through ERK signaling pathway, we 
used the specific inhibitor of mitogen-activated protein kinase kinase (MEK), PD98059. Inhibition of 
MEK activity, which is the upstream kinase of ERK, blocks ERK signaling32. PG-induced 
phosphorylation of ERK1/2 was significantly decreased in response to PD98059 treatment (Fig. 5A). 
In adipocyte differentiation condition, co-treatment of PD98059 restored PG-mediated inhibition of 
lipid accumulation (Fig. 5B). Additionally, 20 μM PD98059 rescues the expression of adipocyte 
specific protein aP2 in a dose dependent manner (Fig. 5C). It demonstrates that PG supress adipocyte 
differentiation via ERK pathway. On the other hand, inhibition of p38 signal pathway by specific 
inhibitors SP203580 did not affect the anti-adipogenic activity of PG (Fig. 5B). Therefore, these 
results support that PG prevents adipocyte differentiation, possibly through sustained ERK activity 
without the activation of other MAPKs. 
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Figure 2 - 4. PG activates phosphorylation of ERK1/2 and p38 in hAMSCs 
(A) hAMSCs were treated with 10uM PG in serum-starvation conditions and the cells were 
harvested at various indicated time. Phosphorylation of ERK1/2, JNK and p38 was examined with 
immunoblotting. (B), (C) hAMSCs were incubated with or without PG (10 µM) in AIM and cells are 
harvested at indicated time. Phosphorylation of ERK1/2 and p38 and expression of ERK2 and β - 
actin were examined by immunoblotting.  
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Figure 2 - 5. PG negatively regulate adipocyte differentiation through ERK activation 
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Figure 2 - 5. PG negatively regulate adipocyte differentiation through ERK activation 
(A) Vehicle or PD98059 was pre-treated for 1 h, and hMSCs were additionally incubated with AIM 
containing 10 uM PG. At 30 min after treatment of PG with AIM, p-ERK1/2 was presented by 
immunoblotting. (B) hAMSCs were cultured in adipocyte differentiation condition with or without 
PG (10 uM) and effect of PD98059 or SB203580 was examined. After adipogenic induction, lipid 
accumulation was estimated by Oil Red O staining at 14 days. (C) Adipogenic marker, aP2, 
expression was examined in PG-treated cells with or without PD98059. Protein level of aP2 was 
examined at day 14 after adipogenic induction. The mean values of venicle -treated cells were 
presented as 100 and others were as its relative values. Data represent the mean ±SD. *p<0.05, 
**p<0.01 
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4. Discussion 
 
PG has been knwon as a synthetic antioxidant in cosmetics, processed food and food packaging 
materials to avoid spoilage and rancidity. The present, Drug Administration and US Food list assure 
safety and effectiveness of PG. Previous studies focused on PG have proprieties of antioxidant, a chemo 
preventive agent and anti-inflammatory factor17b, 33. However, a function of PG on stem cell 
differentiation has not been investigated. This study suggests anti-adipogenic activity of PG in 
hAMSCs. Our results show that PG significantly decreases adipocyte differentiation without cellular 
toxicity and PG inhibits lipid droplets formation. In response to PG treatment, adipogenic markers 
expression also was suppressed during adipocyte differentiation of hAMSCs and the activity of 
PPAR-γ was also decreased. Moreover, the inhibitory effects of PG require ERK activity, but not p38 
activation. To our understanding, this is the first study of PG that inhibits adipocyte differentiation 
through ERK signaling pathway and regulating PPAR-γ activity in hAMSCs. 
During adipocyte differentiation, induced PPAR-γ and C/EBP-α are the key transcriptional 
regulators34. Especially, PPAR-γ expression can promote adipocyte differentiation in absence of  
C/EBP-α, but C/EBP-α cannot induce adipocyte differentiation without PPAR-γ, it shows that PPAR-
γ is a key transcriptional factor of adipocyte differentiation35. PPAR-γ is known as a member of the 
nuclear receptor superfamily of ligand-induced transcription factors36. No factor has been found out 
that induced adipocyte differentiation without PPAR-γ and most adipogenic factors can modulate the 
adipocyte differentiation via modulation of PPAR-γ activity and expression. For example, some 
flavonoids such as vitexin, orientin, and lovastatin inhibit adipocyte differentiation by inhibiting 
PPAR-γ expression in bone marrow-derived mesenchymal cell37. We also observed PG decreased 
PPAR-γ expression in adipocyte differentiation from hAMSC. Furthermore we examine that PG has 
the effect on PPAR-γ activation. The results show that PG inhibits the activity of PPAR-γ in HEK293 
cells (Fig. 3). Taken together, those results indicate that PG suppresses the adipocyte differentiation of 
hAMSC through decreasing the expression and activation of PPAR-γ. 
Recently, several reports demonstrated that anti-adipogenic compounds induce activation of MAPK 
and inhibit adipocyte differentiation through MAPK signal pathway12. For example, Ochratoxin A, is 
as food-contaminating mycotoxins, suppresses adipocyte differentiation via activation of ERK23a. 
Wedelolatone, which is naturally occurring coumestan and used for septic shock patient, has been 
known to suppress adipocyte differentiation via phosphorylation of ERK and JNK in bone marrow 
stromal cells38. ERK has significant control function on stem cell differentiation and ERK inhibitor, 
PD98059, is known for induction of adipocyte differentiation. PG promotes ERK and p38 under 
serum-free conditions (Fig. 4A). And in AIM condition, PG activates ERK1/2 phosphorylation, and 
treatment of MEK inhibitor, PD98059, rescues the inhibitory activity of PG in adipocyte 
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differentiation. But a p38-specific inhibitor could not recover adipocyte differentiation (Fig. 5B). 
Therefore, our results demonstrate that PG suppresses adipocyte differentiation in ERK-dependent 
manner. In addition, PG decreases PPAR-γ activity. PPAR-γ can be regulated through ERK activation. 
The ERK pathway causes S112 phosphorylation of PPAR-γ and phosphorylation of PPAR-γ inhibits 
the RXR/PPAR- heterodimers activity on PPREs and it can inhibit adipocyte differentiation39. 
Therefore, we can assume that activated ERK cascade by PG contributes to regulation of PPAR-γ 
genomic action through phosphorylation of PPAR-γ.  
Obesity, which stands for as abnormal or immoderate lipid accumulation, cause global issue such 
as type II diabetes, hypertension, cardiovascular diseases and certain cancers20. A great deal of 
researchers has focused on study and treatment of obesity through inhibition of adipocyte 
differentiation. This report provides the possibility of obesity care through PG stimulated- inhibition 
of adipocyte differentiation. And then, to confirm the possibility, we need to discover the function of 
PG in animal model in further study. 
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5. Conclusion  
 
We demonstrate a novel effect of PG in adipocyte differentiation of hAMSCs. PG reduces lipid 
droplets formation and adipogenic marker expression in hAMSCs. Especially, we reveal that 
activation of PPAR-γ, which works as a major transcriptional factor in adipocyte differentiation, was 
decreased in PG condition and PG inhibits adipocyte differentiation via ERK activity. Furthermore, 
these results suggest that PG can be used as anti-obesity food additives. 
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배우려고 하시는 남다름 선생님께 고맙다는 인사 드리며 같이 먹었던 점심시간은 정말 
즐거웠다는 말 하고 싶습니다.  
대학원 생활 동안 실험실 식구들뿐만 아니라 교수님들과 연구원 선생님들까지 저에게 많
은 도움을 주셨습니다. 저의 고민상담을 귀 기울여 듣고 조언을 해주신 박수아 선생님, 
지금은 동물실 일원이 되셨지만 저희 실험실에서 실장님을 하시며 수고하셨던 김일신 선
생님, 동물사육에 관련해서 많이 가르쳐 주시고 도움주신 박경수 선생님, 현미경 사용하
고 있으면 들어오셔서 도움을 주신 허진회 선생님 그리고 저에게 커피를 내려주며 고민
상담을 들어준 황수현 선생님 고맙습니다. 또한 저의 연구가 시작될 수 있도록 시작점을 
찍어 저에게 큰 도움을 주신 최웅규 교수님, 저의 인턴 기간 동안 저를 지도해주신 서정
곤 박사님, 한 때는 저희와 같이 실험실을 사용하면서 같은 실험실 식구처럼 지냈던 권
혁무 교수님 실험실 식구들에게도 감사의 말을 전하고 싶습니다.  
대학원 수업을 하면서 친해진 친구들은 힘들 대학원 생활에서 서로 고민상담하고 서로 
위로하며 만든 소중한 인연들 이였습니다. 제일 큰 고민부터 제일 사소한 고민까지 모두 
털어놓으며 많은 이야기를 한 임지원 오빠, 밥 한번 먹자는 말로 서로에게 할 이야기가 
있다는 것을 알게 되는 조주형 오빠, 멀리서 보여도 반가워서 손 먼저 흔들고 반갑게 인
사하는 봉서, 언니 언니 하며 반갑게 인사하는 게 너무 귀여운 은진이, 의젓한 듯 보이지
만 여린 마음에 고민이 많은 환희까지 모두 만나면 반겨주고 힘이 들 때 도와주고 챙겨
줘서 고맙다는 마음을 전하고 싶습니다.  
제가 공부하는 동안 저에게 가족들은 저를 항상 믿고 지지해주는 큰 버팀목 이였습니다. 
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늦게까지 공부하느라 힘들지 않냐며 항상 저를 걱정해주시는 우리 아빠, 점심 도시락을 
준비해주시며 오늘 하루도 힘내라고 힘이 되어주신 우리 엄마, 언니 노릇을 할 수 있도
록 언니를 항상 믿고 따라와주는 친구 같은 동생 지은이 그리고 울산 떠나 포항에서 공
부하느라 힘든 막내 동생 건희까지 우리 가족 모두에게 항상 고맙고 사랑한다는 말을 전
하고 싶습니다. 
석사 과정은 공부하고 실험하며 많은 지식을 얻어 한층 더 나아갈 수 발판이 될 것이라
고 생각했었습니다. 하지만 학위 과정의 끝에 있는 지금 제가 얻은 것은 지식으로 만든 
논문과 한 장의 석사 학위 졸업장 뿐만 아니라 많은 사람들을 만나 서로 도와가며 쌓아
가는 서로에 대한 신뢰를 배워가는 과정이었습니다. 제가 인턴생활을 시작으로 석사 학
위를 받고 졸업하는 지금까지 도와주신 모든 분들 감사합니다. 지금이 끝이 아니라 시작
이라는 말처럼 앞으로 더욱 열심히 하겠습니다.  
 
